316 related articles for article (PubMed ID: 32523311)
41. The Role of Microbiota on the Gut Immunology.
Min YW; Rhee PL
Clin Ther; 2015 May; 37(5):968-75. PubMed ID: 25846321
[TBL] [Abstract][Full Text] [Related]
42. γδ T cells bring unconventional cancer-targeting to the clinic - again.
Garber K
Nat Biotechnol; 2020 Apr; 38(4):389-391. PubMed ID: 32265560
[No Abstract] [Full Text] [Related]
43. Deficiency of γδT cells protects against abdominal aortic aneurysms by regulating phosphoinositide 3-kinase/AKT signaling.
Zhang S; Kan X; Li Y; Li P; Zhang C; Li G; Du J; You B
J Vasc Surg; 2018 Mar; 67(3):899-908.e1. PubMed ID: 28024851
[TBL] [Abstract][Full Text] [Related]
44. γδT Cells and Related Diseases.
Lu H; Li DJ; Jin LP
Am J Reprod Immunol; 2016 Jun; 75(6):609-18. PubMed ID: 26833725
[TBL] [Abstract][Full Text] [Related]
45. Wnt pathway activator TWS119 enhances the proliferation and cytolytic activity of human γδT cells against colon cancer.
Chen YQ; Zheng L; Aldarouish M; Zhou ZH; Pan N; Liu JQ; Chen FX; Wang LX
Exp Cell Res; 2018 Jan; 362(1):63-71. PubMed ID: 29104081
[TBL] [Abstract][Full Text] [Related]
46. Cruel to Be Kind: Epithelial, Microbial, and Immune Cell Interactions in Gastrointestinal Cancers.
Shalapour S; Karin M
Annu Rev Immunol; 2020 Apr; 38():649-671. PubMed ID: 32040356
[TBL] [Abstract][Full Text] [Related]
47. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
[TBL] [Abstract][Full Text] [Related]
48. The role of gut microbiota in intestinal and liver diseases.
Hrncir T; Hrncirova L; Kverka M; Tlaskalova-Hogenova H
Lab Anim; 2019 Jun; 53(3):271-280. PubMed ID: 30580671
[TBL] [Abstract][Full Text] [Related]
49. Roles of intestinal epithelial cells in the maintenance of gut homeostasis.
Okumura R; Takeda K
Exp Mol Med; 2017 May; 49(5):e338. PubMed ID: 28546564
[TBL] [Abstract][Full Text] [Related]
50. Get in Touch With Dendritic Epithelial T Cells!
Thelen F; Witherden DA
Front Immunol; 2020; 11():1656. PubMed ID: 32849572
[TBL] [Abstract][Full Text] [Related]
51. The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases.
Xu H; Liu M; Cao J; Li X; Fan D; Xia Y; Lu X; Li J; Ju D; Zhao H
J Immunol Res; 2019; 2019():7546047. PubMed ID: 31772949
[TBL] [Abstract][Full Text] [Related]
52. The microbiota in adaptive immune homeostasis and disease.
Honda K; Littman DR
Nature; 2016 Jul; 535(7610):75-84. PubMed ID: 27383982
[TBL] [Abstract][Full Text] [Related]
53. The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer.
Cianci R; Franza L; Schinzari G; Rossi E; Ianiro G; Tortora G; Gasbarrini A; Gambassi G; Cammarota G
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30682772
[TBL] [Abstract][Full Text] [Related]
54. Microbiome and pathogen interaction with the immune system.
Kogut MH; Lee A; Santin E
Poult Sci; 2020 Apr; 99(4):1906-1913. PubMed ID: 32241470
[TBL] [Abstract][Full Text] [Related]
55. NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer.
Mikulak J; Oriolo F; Bruni E; Roberto A; Colombo FS; Villa A; Bosticardo M; Bortolomai I; Lo Presti E; Meraviglia S; Dieli F; Vetrano S; Danese S; Della Bella S; Carvello MM; Sacchi M; Cugini G; Colombo G; Klinger M; Spaggiari P; Roncalli M; Prinz I; Ravens S; di Lorenzo B; Marcenaro E; Silva-Santos B; Spinelli A; Mavilio D
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31689241
[TBL] [Abstract][Full Text] [Related]
56. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
[TBL] [Abstract][Full Text] [Related]
57. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles.
Miranda-Ribera A; Ennamorati M; Serena G; Cetinbas M; Lan J; Sadreyev RI; Jain N; Fasano A; Fiorentino M
Front Immunol; 2019; 10():2233. PubMed ID: 31608059
[TBL] [Abstract][Full Text] [Related]
58. Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity.
Brown EM; Kenny DJ; Xavier RJ
Annu Rev Immunol; 2019 Apr; 37():599-624. PubMed ID: 31026411
[TBL] [Abstract][Full Text] [Related]
59. The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life.
Ganal-Vonarburg SC; Duerr CU
Immunology; 2020 Jan; 159(1):39-51. PubMed ID: 31777064
[TBL] [Abstract][Full Text] [Related]
60. Gut-liver axis signaling in portal hypertension.
Simbrunner B; Mandorfer M; Trauner M; Reiberger T
World J Gastroenterol; 2019 Oct; 25(39):5897-5917. PubMed ID: 31660028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
